Ignite Creation Date:
2025-12-25 @ 1:25 AM
Ignite Modification Date:
2026-03-03 @ 2:32 AM
Study NCT ID:
NCT05740293
Status:
COMPLETED
Last Update Posted:
2025-08-29
First Post:
2023-02-07
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Post-approval Study of New Enrolment Patients Undergoing Bilateral Treatment With the VisuMax SMILE Procedure
Sponsor:
Carl Zeiss Meditec, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
VisuMax-2018-PAS01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None